Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07217574 · ClinicalTrials.gov registry record

Program in Oncology for Tribal Health Systems.

A clinical trial of Patient Outcomes, sponsored by University of Oklahoma.

Recruiting
Registry status
187
Enrollment target
1
Study location

NCT07217574 is a study of Patient Outcomes that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 187 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07217574, a study of Patient Outcomes, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
187 participants
Enrollment target
1
Study location

Study Summary

This clinical trial aims to develop and implement more navigation assistance programs tailored specifically for Native American cancer patients, addressing the current lack of available support. The goal is to improve communication barriers within the healthcare system by fostering a collaborative approach between the Stephenson Cancer Center (SCC) and tribally operated healthcare systems (ITU). Through this partnership, the trial seeks to enhance patient outcomes by providing culturally sensitive, coordinated care.

Conditions Studied

Interventions

  • OTHER C3PO

Study Locations (1)

Oklahoma

  • OU Health Stephenson Cancer Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2026-03
Est. Completion 2031-03

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT07217574

The ClinicalTrials.gov registry entry for NCT07217574 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Patient Outcomes appearing as the primary indexed condition, and to 1 intervention - of which C3PO is the first listed.

NCT07217574 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT07217574 about?

NCT07217574 is a clinical study titled "Program in Oncology for Tribal Health Systems.". This clinical trial aims to develop and implement more navigation assistance programs tailored specifically for Native American cancer patients, addressing the current lack of available support. The goal is to improve communication barriers within the healthcare system by fostering a collaborative a...

What is the current status of trial NCT07217574?

This trial is currently recruiting. The enrollment target is 187 participants. The study started on 2026-03. Estimated completion is 2031-03.

What conditions does trial NCT07217574 study?

This clinical trial studies the following conditions: Patient Outcomes.

What interventions are being tested in trial NCT07217574?

The interventions under investigation include: C3PO (OTHER).

Who is sponsoring clinical trial NCT07217574?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07217574 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Outcomes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.